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Abstract Gain-of-function mutations in the transcription fac-
tors Pdr1p and Pdr3p lead to the up-regulation of genes
controlling plasma membrane properties. Pdr3p is involved in a
retrograde response in which mitochondrial dysfunctions activate
PDR5, a gene encoding an ABC membrane transporter. We
carried out genome-wide analyses of the PDR3-controlled genes
activated by the deletion of the mitochondrial DNA. We present
evidence showing that PDR1 does not interfere with this PDR3
response. We also showed that the mitochondrially activated
PDR3 response is highly sensitive to both yeast strain variations
and carbon sources. These observations explain the apparent
discrepancies in published studies and better describe the
connections between the mitochondrial state and plasma
membrane properties. ß 2001 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Mitochondria play a fundamental role in cell physiology,
producing cellular energy, essential metabolites and reactive
oxygen species. Mitochondrial activity is tightly controlled by
the nucleus, yet numerous signals originate from mitochon-
dria and in£uence nuclear gene expression and thus biochem-
ical pathways in the whole cell [1]. In fungi, the mitochondrial
control of nuclear gene expression is called the retrograde
response. It has been characterized in yeast cells lacking the
mitochondrial genome (rho0 cells) and it was shown that a
respiratory de¢ciency induces a suite of genes associated with
both peroxisomal activities and metabolite-restoration path-
ways [2]. This transcriptional retrograde response is controlled
by two transcription factors: Rtg1p and Rtg3p [3]. Epstein et
al. [2] used genome-wide microarrays to show that the rho0
phenotype induces extensive changes in gene expression, only
a small number of which are dependent on RTG genes. This
suggests that other transcription regulation networks are con-
nected to mitochondria signalling pathways [2]. For example,
a large number of genes involved in pleiotropic drug resis-
tance (PDR) are activated in rho0 cells [4]. Two major regu-
lators of the PDR phenomenon have been identi¢ed in Sac-
charomyces cerevisiae, Pdr1p and Pdr3p [5,6]. Pdr1p and
Pdr3p are close homologues and recent genome-wide studies
have shown that their activities largely overlap. About 20
target genes have been identi¢ed. These mainly encode ABC
transporters (e.g. PDR5), permeases and proteins involved in
membrane biogenesis [7,8]. PDR3 controls its own transcrip-
tion and can also be regulated by Pdr1p [9]. Hallstrom et al.
[10] screened for negative regulators of PDR5 expression and
described a PDR3-speci¢c activation of PDR5 transcription in
cells lacking the mitochondrial genome and in cells deleted for
components of the electron transport chain [11]. These e¡ects
were correlated with the resistance of rho0 cells to a large
number of drugs. We used whole-genome microarrays to com-
plete the list of genes up-regulated in rho0 cells. We showed
that all of the mitochondria-dependent PDR e¡ects are de-
pendent on an increase in PDR3 expression and independent
of PDR1 activity. We suggest that, for some of these genes,
PDR3 requires speci¢c factors other than the rho0 status of
the cells to mediate transcriptional activation. Finally, we ob-
served that PDR activation in rho0 cells is in£uenced by both
the carbon source and the background of the strains. These
results imply that there is a tight link between PDR3 activity
and mitochondrial activity, independently of any drug treat-
ment. This genome-wide study provides an overview of the
control that mitochondria status exerts on membrane proper-
ties.
2. Materials and methods
2.1. Yeast strains and growth conditions
The strains FY1679-28C (MatK ura3-52 trp1v63 leu2v1 his3v200)
and SEY6210 (MatK ura3-52 trp1v901 leu2-3 his3v200 suc2v9 lys2-
801) and their derivatives FYvpdr3 (FY1679 vpdr3: :HIS3), FYvpdr1
(FY1679 vpdr1: :TRP1), FYvpdr3vpdr1 (FY1679 vpdr3: :HIS3
vpdr1: :TRP1) and SEYvpdr3 (SEY6210 vpdr3: :HisG) were used
for genome-wide analyses of the role of PDR1 and PDR3 in rho0
and rho+ cells. Strain EC70 (FY1679 vpdr3: :HIS3: :PDR3-7
vpdr1: :TRP1) was constructed in this study. Strain PSY142 (MatK
ura3 leu2 lys2) and its isogenic rho0 derivative were kindly provided
by Ronald Butow. Strains W303-1B (MatK ura3-1 ade2-1 trp1 leu2-3
his3-11 suc2v9 lys2-801 can1-100) and BY4742 (MATK his3v1 leu2v0
lys2v0 ura3v0) were used for Northern blot analyses of PDR3 and
PDR5 expression. Strains were grown in a rich medium containing 1%
yeast extract, 1% bactopeptone and 2% of the corresponding carbon
source. Cells were grown at 30‡C to an OD600nm of 0.6^0.8. They were
collected by centrifugation and frozen at 380‡C prior to RNA ex-
traction.
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2.2. Ethidium bromide treatment
The rho0 derivatives of the strains described above were obtained
by plating the cells twice on agar plates containing 40 Wg/ml ethidium
bromide (2% glucose, 1% yeast extract, 1% bactopeptone, 20 mg/l
adenine, 0.05 M phosphate bu¡er pH 6.2, 2% agar, 40 Wg/ml ethidium
bromide).
2.3. RNA extraction and microarray analyses
mRNA was puri¢ed using the Micro-Fasttrack 2.0 system from
Invitrogen. Yeast microarrays were obtained from Hitachi Software
and DNAChip Research. 2 Wg of mRNA was used for reverse tran-
scription reactions. Detailed protocols are available at www.biolo-
gie.ens.fr/fr/genetiqu/puces/protocoles puces.html. The arrays were an-
alyzed with the Genepix 3.0 software. We excluded artefactual spots,
saturated spots and low signal spots. Assuming that the expression of
most genes was unchanged, the Cy3/Cy5 ratios were normalized by
use of the median of all the ratios for each experiment using Array-
plot (Marc et al., submitted). The cluster images shown in Figs. 1 and
2 were generated by Treeview [20].
2.4. Northern blot analyses
Total RNA (15 Wg) was denatured in formamide at 65‡C and sep-
arated on a 1.5% agarose gel. Northern analyses were performed as
described previously [21]. Probes were radioactively labelled using the
Klenow enzyme and the Nonaprimer labelling kit (Q-Biogene).
3. Results
3.1. Genome-wide analysis of the rho0-mediated activation of
Pdr3p
We used ¢ve strains throughout this study: SEY 6210, FY
1679-18B, W303-1B, BY4742 and PSY142. For the sake of
simplicity, they will be called SEY, FY, W303, BY and PSY,
respectively. The form of Pdr3p that is activated by mitochon-
drial dysfunction will be called Pdr3p*.
We carried out a genome-wide study on the transcriptome
modi¢cations induced by the production of Pdr3p* in SEY
and FY. SEY was chosen because it is the ¢rst strain in which
the role of Pdr3p* was demonstrated [10]. Rho0 derivatives of
the appropriate strains were constructed by classical methods.
Comparative transcriptome analyses, using cDNA-based mi-
croarrays containing most of the yeast open reading frames,
were conducted in triplicate on wild-type and rho0 strains,
and on rho0 strains in the presence or absence of PDR3.
The ¢rst type of experiments reveals the global e¡ects of the
rho0 phenotype in these two strains (Fig. 1, ¢rst and third
columns), and the second experiment points out the nuclear
genes which are speci¢cally up- or down-regulated by Pdr3p*
(Fig. 1, second and fourth columns). The genes induced in
both cases (Fig. 1A) probably respond to mitochondrial dys-
function via PDR3. The fact that all of these genes contain at
least one PDR-responsive element in their promoter region
suggests that Pdr3p* directly interacts with these promoters.
The six genes in group B (Fig. 1) might also be direct targets
of Pdr3p*, but they behaved di¡erently in the two strains.
Finally, many genes were up-regulated in a PDR3-indepen-
dent manner in the rho0 context (Fig. 1C). Most of these
genes have previously been characterized and depend on other
pathways of cross-talk between mitochondria and nucleus [4].
The RTG network is the best characterized. The RTG genes
activated by mitochondrial dysfunction include several genes
involved in peroxisome biogenesis [2]. The genes that respond
C
Fig. 1. Genes activated by Pdr3p* in rho0 cells. The transcription
pro¢les of 54 genes, the expression of which changed signi¢cantly in
both SEY (cluster on the left) and FY (cluster on the right) follow-
ing the loss of mtDNA (¢rst column), were arranged according to
their PDR3 dependence (second column). The blue dots indicate
PDR-responsive elements in the corresponding promoters. A: Genes
whose activation is dependent on PDR3. B: Genes whose activation
is dependent on PDR3 in either FY or SEY background. C: Genes
whose activation is independent of PDR3. All of the information
for YPD [22] is mentioned. Changes in expression are indicated by
a colored bar in the bottom right corner. The corresponding values
are given in Table 1 at www.biologie.ens.fr/yeast-publi.html.
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to RTG were poorly activated in our experiments. Both strain
di¡erence and growth in glucose rather than in ra⁄nose ex-
plain this di¡erence (see below). Additionally, a group of
genes involved in iron uptake and homeostasis was activated
as a result of the mtDNA defect. This group includes two
siderophore transporters (Taf1p and Arn1p), two unknown
membrane proteins (Fit1p and Fit2p) thought to be iron up-
take facilitators [12], and the regulator, Tis11p [13].
3.2. Variations in strains and growth conditions modulate the
activation of Pdr3p*
3.2.1. Pdr3p activity is not dependent on PDR1 in rho0
cells. Pdr3p and Pdr1p have essentially the same targets in
wild-type cells [8]. Moreover, when Pdr1p is overexpressed it
can positively regulate the PDR3 promoter [9]. However, the
role of Pdr1p in the activation of Pdr3p* targets is ambigu-
ous. As shown by L-galactosidase assays, the activation of
PDR5 in cells de¢cient for mitochondrial function is not de-
pendent on PDR1 [10]. On the other hand, the activation of a
PDR5-LacZ reporter in rho0 cells has been found to be
slightly modulated by PDR1 [14]. Given these data, we at-
tempted to determine the role of PDR1 in the rho0 activation
of PDR targets. Remarkably, the deletion of PDR1 from rho0
cells had no e¡ect on the activation of the Pdr3p*-dependent
genes, as shown by microarray (Fig. 2A,B) and Northern blot
(data not shown) analyses. According to these results, Pdr3p*
activity is independent of PDR1.
3.2.2. The insertion of the PDR3-7 gain-of-function allele
into the genome of rho+ cells partially mimics the e¡ects of
mtDNA loss. As shown by Hallstrom et al. [10], the activa-
tion of PDR3 transcription in rho0 cells is dependent on the
post-transcriptional activation of Pdr3p itself. Thus, we de-
cided to determine whether a Pdr3p gain-of-function mutant
in a rho+ background would be able to reproduce the PDR
activation observed in rho0 cells. Therefore, we compared the
transcriptomes of cells deleted for PDR3 and PDR1 with the
same cells carrying a genomic insertion of the gain-of-function
allele PDR3-7 at the PDR3 locus. Pdr3-7p activated the tran-
scription of PDR5, PDR15, YOR049c, YAL061w, YOR152c,
SNQ2, PDR10 and PDR3-7 itself (Fig. 2A). Interestingly,
PDR3-7 did not activate YKL071w, YGR035c, ICT1 or
YLR346c (Fig. 2B). All of these genes except YLR346c had
previously been reported to be independent of PDR3-7 carried
on a centromeric plasmid [8]. This implies that Pdr3p alone
cannot activate these genes and that some other factors acti-
vated in rho0 but not in rho+ cells are required.
3.2.3. The rho0-mediated PDR activation depends on the
carbon source and is sensitive to strain variations. The above
results, together with previous ones, demonstrated the intri-
cate relation between rho0 phenotype and the PDR network.
However, similar microarray experiments carried out by Ep-
stein et al. [2] on rho0 cells of PSY background grown in
ra⁄nose gave quite di¡erent results. In these conditions,
none of the PDR targets were activated. This raised the ques-
tion of whether the PSY strain can activate PDR3 following
the loss of mtDNA and whether the carbon source a¡ects
Fig. 2. E¡ect of PDR1 and the gain-of-function allele, PDR3-7, on
the genes activated by Pdr3p* in rho0 cells. The transcription pro-
¢les of 23 genes, the expression of which signi¢cantly changed in
FY background following the loss of mtDNA (¢rst cluster on the
left), were arranged according to their sensitivity to PDR1 activity
in rho0 cells (second cluster, ¢rst column) and to PDR3-7 depen-
dence (second cluster, third column) in rho+ cells. A: Pdr3p*-de-
pendent genes whose activation is independent of PDR1 in rho0
cells and dependent on PDR3-7 in rho+ cells. B: Pdr3p*-dependent
genes whose activation is independent of PDR1 on rho0 cells and
of PDR3-7 in rho+ cells. The corresponding values are given in Ta-
ble 1 at www.biologie.ens.fr/yeast-publi.html.
Fig. 3. Northern blot analyses of the amount of PDR3 and PDR5
mRNA in rho0 and rho+ cells from di¡erent backgrounds grown
on di¡erent carbon sources. A: Glucose. B: Ra⁄nose. C: Galac-
tose. No Growth: The invertase gene (SUC2) of SEY contains a
mutation and thus SEY fails to grow on ra⁄nose. The PSY rho0
strain did not grow on galactose.
Fig. 4. Multiple signals regulating nuclear gene expression originate
from mitochondria dysfunction. PX: peroxisome. OXPH: oxidative
phosphorylation.
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Pdr3p activity. To address these points, we investigated gene
expression in rho0 cells in ¢ve di¡erent backgrounds (PSY,
W303, FY, BY, SEY), grown on three di¡erent carbon sour-
ces (glucose, ra⁄nose, galactose). Northern blot analyses us-
ing PDR3 and PDR5 probes as controls for PDR activation
showed that PDR activation occurs in all rho0 cells grown in
glucose (Fig. 3A). However, PSY and BY strains could not
activate PDR3 or PDR5 when grown in ra⁄nose, whereas FY
and W303 exhibited the same PDR activation as in glucose
(Fig. 3B). To determine whether this e¡ect was due to the low
fermentative rate of ra⁄nose compared with glucose we in-
vestigated the rho0-mediated activation of PDR5 in galactose,
which like ra⁄nose is a poor substrate for fermentation. Sur-
prisingly, all of the strains tested, including BY, were able to
activate PDR5 in a rho0 background (Fig. 3C). Therefore, the
di¡erences observed in ra⁄nose and in glucose were not
caused by a di¡erence in the metabolic rates, and the PDR
response of rho0 cells is not speci¢c to glucose repressive
conditions.
4. Discussion
4.1. Pdr3p is activated by mitochondrial dysfunction
Alterations in mitochondrial function modify the expression
of a large number of genes [2] [4]. Each of these changes has
to be analyzed individually to distinguish direct e¡ects from
indirect e¡ects. We con¢rmed, at the genome level, that mi-
tochondrial dysfunction activates the transcription factor
Pdr3p in a form (Pdr3p*) which remains to be understood
(Fig. 4). We nevertheless o¡er several clues on the properties
of this Pdr3p* form. We show that 11 (or possibly 14) genes
are targets of Pdr3p* (Fig. 1A,B). Interestingly, a genomic
version of PDR3, carrying the gain-of-function allele,
PDR3-7, had fewer target genes. At least three genes (ICT1,
YGR035C and YKL071W) are up-regulated by Pdr3p* but
not regulated by the gain-of-function mutant. This suggests
that other transcription factors act in concert with Pdr3p*.
Although Pdr1p and Pdr3p are very similar, Pdr1p is not
involved in this process. This shows that although PDR1
and PDR3 control similar sets of target genes, their own reg-
ulation is very di¡erent. This is true at the transcription level
(only PDR3 is autoregulated [9]), at the nucleus import level
(the L-karyopherins di¡er [15]) and at the post-translational
level (mitochondria dysfunction only activates Pdr3p [10] and
this study). Interestingly, the overexpression of PDR3 is con-
nected with the suppression of mitochondrial import defects
[16]. However, the genes involved in this process, like TOM72,
are probably not activated directly by Pdr3p*.
4.2. Di¡erent yeast strains elicit di¡erent PDR3-controlled
responses
One important aspect of this work is the clear demonstra-
tion that the activation of Pdr3p* is dependent on both the
yeast strains and the carbon sources used. This clari¢es the
con£icting data in the literature, which reported di¡erences in
the nuclear responses to mitochondrial dysfunction [2,4]. We
did not ¢nd an active form of Pdr3p* in PSY or BY strains
when they were grown on ra⁄nose, whereas the PDR3 au-
toactivation process was clearly observed in W303 or FY
strains grown in the same conditions. The carbon source in-
£uences this phenotype, as shown by the fact that when PSY
or BY were grown in glucose the PDR3 autoactivation pro-
cess occurred as in W303 and FY. It is di⁄cult to known
whether carbon metabolism a¡ects the mitochondrial re-
sponse in a strain-dependent manner because we do not
know the nature of the molecular process that controls the
activation of Pdr3p. It has been suggested that glutamate
levels are a key signalling component in the retrograde re-
sponse pathway [17]. Alternatively, the mitochondrial
NADH has been proposed to be a signalling molecule in
mammalian cells [18]. The NADH/NAD level, which re£ects
the electron transport chain activity, might activate Pdr3p in
rho0 cells. Finally, the speci¢c features of the PSY and BY
strains provide a convenient model to screen for regulators
that could restore PDR3 activity on ra⁄nose. The identi¢ca-
tion of such regulators will greatly improve our understanding
of the physiological regulation of Pdr3p activity and may help
us to identify the signalling pathways that connect mitochon-
dria activity to membrane properties in yeast. Such a connec-
tion between mitochondrial DNA status and membrane dam-
age has been shown to contribute to tumor progression and
metastasis in human cells [19].
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